158 related articles for article (PubMed ID: 33721670)
1. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S
Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of 4-fluorophenyl-imidazole p38α MAPK, CK1δ and JAK2 kinase inhibitors.
Seerden JP; Leusink-Ionescu G; Woudenberg-Vrenken T; Dros B; Molema G; Kamps JA; Kellogg RM
Bioorg Med Chem Lett; 2014 Aug; 24(15):3412-8. PubMed ID: 24930833
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
4. A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.
Redenti S; Marcovich I; De Vita T; Pérez C; De Zorzi R; Demitri N; Perez DI; Bottegoni G; Bisignano P; Bissaro M; Moro S; Martinez A; Storici P; Spalluto G; Cavalli A; Federico S
ChemMedChem; 2019 Feb; 14(3):310-314. PubMed ID: 30548443
[TBL] [Abstract][Full Text] [Related]
5. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
6. A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ.
Bolcato G; Cescon E; Pavan M; Bissaro M; Bassani D; Federico S; Spalluto G; Sturlese M; Moro S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575906
[TBL] [Abstract][Full Text] [Related]
7. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Wang L; Liu X; Duan Y; Li X; Zhao B; Wang C; Xiao Z; Zheng P; Tang Q; Zhu W
Chem Biol Drug Des; 2018 Jul; 92(1):1301-1314. PubMed ID: 29575727
[TBL] [Abstract][Full Text] [Related]
10. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
[TBL] [Abstract][Full Text] [Related]
11. Kinase and GPCR polypharmacological approach for the identification of efficient anticancer medicines.
Park H; Jung HY; Mah S; Kim K; Hong S
Org Biomol Chem; 2020 Oct; 18(41):8402-8413. PubMed ID: 33112339
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors.
Bera H; Dolzhenko AV; Sun L; Dutta Gupta S; Chui WK
Chem Biol Drug Des; 2013 Sep; 82(3):351-60. PubMed ID: 23758794
[TBL] [Abstract][Full Text] [Related]
13. Chloromethylhalicyclamine B, a Marine-Derived Protein Kinase CK1δ/ε Inhibitor.
Esposito G; Bourguet-Kondracki ML; Mai LH; Longeon A; Teta R; Meijer L; Van Soest R; Mangoni A; Costantino V
J Nat Prod; 2016 Nov; 79(11):2953-2960. PubMed ID: 27933894
[TBL] [Abstract][Full Text] [Related]
14. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel 1,2,4-triazolo-1,2,4-triazines with thiomethylpyridine hinge binders as potent c-Met kinase inhibitors.
Dadashpour S; Kϋçϋkkılınç TT; Ayazgök B; Hosseinimehr SJ; Chippindale AM; Foroumadi A; Irannejad H
Future Med Chem; 2019 May; 11(10):1119-1136. PubMed ID: 31280674
[No Abstract] [Full Text] [Related]
17. Ligand-protein interactions of selective casein kinase 1δ inhibitors.
Mente S; Arnold E; Butler T; Chakrapani S; Chandrasekaran R; Cherry K; DiRico K; Doran A; Fisher K; Galatsis P; Green M; Hayward M; Humphrey J; Knafels J; Li J; Liu S; Marconi M; McDonald S; Ohren J; Paradis V; Sneed B; Walton K; Wager T
J Med Chem; 2013 Sep; 56(17):6819-28. PubMed ID: 23919824
[TBL] [Abstract][Full Text] [Related]
18. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
[TBL] [Abstract][Full Text] [Related]
19. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.
Bibian M; Rahaim RJ; Choi JY; Noguchi Y; Schürer S; Chen W; Nakanishi S; Licht K; Rosenberg LH; Li L; Feng Y; Cameron MD; Duckett DR; Cleveland JL; Roush WR
Bioorg Med Chem Lett; 2013 Aug; 23(15):4374-80. PubMed ID: 23787102
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
Bera H; Lee MH; Sun L; Dolzhenko AV; Chui WK
Bioorg Chem; 2013 Oct; 50():34-40. PubMed ID: 23968897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
